Antibiotic susceptibility profile of Helicobacter pylori isolated from the dyspepsia patients in Tehran, Iran

Saudi Journal of Gastroenterology

Volumn 17, Issue 4, 2011, Pages 261-264

  Shokrzadeh, Leila ^a   Jafari, Fereshteh ^a   Dabiri, Hossein ^a   Baghaei, Kaveh ^a   Zojaji, Homayoun ^a   Alizadeh, Amir H ^a   Aslani, Mohammad Mehdi ^a,b   Zali, Mohammad R ^a  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b PASTEUR INSTITUTE OF IRAN   (Iran)

Author keywords

Antibiotic susceptibility; Helicobacter pylori; Iranian patients

Indexed keywords

AMOXICILLIN; AMPICILLIN; CIPROFLOXACIN; CLARITHROMYCIN; METRONIDAZOLE; TETRACYCLINE;

ADULT; ANTIBIOTIC SENSITIVITY; ARTICLE; DNA EXTRACTION; DRUG RESISTANCE; DYSPEPSIA; FEMALE; GASTROINTESTINAL DISEASE; GENE AMPLIFICATION; HELICOBACTER PYLORI; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MINIMUM INHIBITORY CONCENTRATION; STOMACH BIOPSY;

ADULT; ANTI-BACTERIAL AGENTS; BIOPSY, NEEDLE; CIPROFLOXACIN; COHORT STUDIES; DRUG RESISTANCE, MULTIPLE, BACTERIAL; DYSPEPSIA; FEMALE; GASTROSCOPY; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; IMMUNOHISTOCHEMISTRY; IRAN; MALE; METRONIDAZOLE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; PROGNOSIS; PROSPECTIVE STUDIES; RISK ASSESSMENT; TETRACYCLINE; URBAN POPULATION;

EID: 79960206432     PISSN: 13193767     EISSN: 19984049     Source Type: Journal    
DOI: 10.4103/1319-3767.82581     Document Type: Article

References (35)

1. Suerbaum S, Michetti P. Helicobacter pylori infection. N Engl J Med 2002;347:1175-86.
2. Malekzadeh R, Sotoudeh M, Derakhshan MH, Mikaeli J, Yazdanbod A, Merat S. Prevalence of gastric precancerous lesions in Ardabil, a high incidence province for gastric adenocarcinoma in the North-West of Iran. J Clin Pathol 2004;57:37-42. (Pubitemid 38091308)
3. Alborzi A, Soltani J, Pourabbas B, Oboodi B, Haghighat M, Hayati M, et al. Prevalence of Helicobacter pylori infection in children (south of Iran). Diagn Microbiol Infect Dis 2006;54:259-61.
4. Graham DY. Campylobacter pylori and peptic ulcer disease. Gastroenterol 1989;96:615-25. (Pubitemid 19038537)
5. Hoffman JS, Cave DR. Treatment of Helicobacter pylori. Curr Opin Gastroenterol 2001;17:30-4. (Pubitemid 32098887)
6. Broutet N, Tchamgoue S, Pereira E, Lamouliatte H, Salamon R, Megraud F. Risk factors for failure of Helicobacter pylori therapy-results of an individual data analysis of 2751 patients. Aliment Pharmacol Ther 2003;17:99-109. (Pubitemid 36140439)
7. Kim JM, Kim JS, Jung HC, Kim N, Kim YJ, Song IS. Distribution of antibiotic MICs for Helicobacter pylori strains over a 16-year period in patients from Seoul, South Korea. Antimicrob Agents Chemother 2004;48:4843-7. (Pubitemid 39577692)
8. Sharara AI, Chedid M, Araj GF, Barada KA, Mourad FH. Prevalence of Helicobacter pylori resistance to metronidazole, clarithromycin, amoxicillin and tetracycline in Lebanon. Int J Antimicrob Agents 2002;19:155-8. (Pubitemid 34168177)
9. Glupczynski Y, Megraud F, Lopez-Brea M, Andersen LP. European multicentre survey of in vitro antimicrobial resistance in Helicobacter pylori. Eur J Clin Microbiol Infect Dis 2001;20:820-3. (Pubitemid 34020461)
10. Kauser F, Hussain MA, Ahmed I, Ahmad N, Habeeb A, Khan AA, et al. Comparative genomics of Helicobacter pylori isolates recovered from ulcer disease patients in England. BMC Microbiol 2005;5:32.
11. National Committee for Clinical Laboratory Standards, Performance standards for antimicrobial susceptibility testing. Fourth Informational Supplement M100-S14, Wayne, PA: NCCLS; 2004.
12. Boyanova L, Koumanova R, Gergova G, Popova M, Mitov I, Kovacheva Y, et al. Prevalence of resistant Helicobacter pylori isolates in Bulgarian children. J Med Microbial 2002;51:786-90.
13. Megraud F, Lehn N, Lind T, Bayerdrffer E, O'Morain C, Spiller R, et al. Antimicrobial susceptibility testing of Helicobacter pylori in a large multicenter trial: the MACH 2 study. Antimicrob Agents Chemother 1999;43:2747-52. (Pubitemid 29519559)
14. Realdi G, Dore MP, Piana A, Atzei A, Carta M, Cugia L. Pretreatment antibiotic resistance in Helicobacter pylori Infection: Results of three randomized controlled studies. Helicobacter 1999;4:106-12. (Pubitemid 129688337)
15. Falsafi T, Mobasheri F, Nariman F, Najafi M. Susceptibilities to different antibiotics of Helicobacter pylori strains isolated from patients at the pediatric medical center of Tehran, Iran. J Clin Microbiol 2004;42:387-9. (Pubitemid 38082753)
16. Fallahi GH, Maleknejad S. Helicobacter pylori culture and antimicrobial resistance in Iran. Indian J Pediatr 2007;74:127-30. (Pubitemid 47305178)
17. Khashei R, Shojaei H, Adibi P, Shavakhi A, Aslani MM, Naser DA. Genetic Diversity and Drug Resistance of Helicobacter pylori Strains in Isfahan, Iran. Iran J Basic Med Sci 2008;11:174-82.
18. Albert JM, Al-Mekhaizeem K, Neil L, Dhar R, Dhar PM, Al-Ali M, et al. High prevalence and level of resistance to metronidazole, but lack of resistance to other antimicrobials in Helicobacter pylori, isolated from a multiracial population in Kuwait. Aliment Pharmacol Ther 2006;24:1359-66. (Pubitemid 44571566)
19. Kim JM, Kim JS, Kim N, Kim SG, Jung HC, Song IS. Comparison of primary and secondary antimicrobial minimum inhibitory concentrations for Helicobacter pylori isolated from Korean patients. Int J Antimicrob Agents 2006;28:6-13.
20. Duck WM, Sobel J, Pruckler JM, Song Q, Swerdlow D, Friedman C, et al. Antimicrobial resistance incidence and risk factors among Helicobacter pylori-infected persons, United States. Emerg Infect Dis 2004;10:1088-94. (Pubitemid 38697703)
21. Sisson G, Jeong JY, Goodwin A, Bryden L, Rossler N, Lim-Morrison S, et al. Metronidazole activation is mutagenic and causes DNA fragmentation in Helicobacter pylori and in Escherichia coli containing a cloned H. pylori RdxA(+) (Nitroreductase) gene. J Bacteriol 2000;182:5091-6.
22. Fakheri H, Malekzadeh R, Merat S, Merat M, Khatibian A, Fazel B, et al. Clarithromycin vs. furazolidone in quadruple therapy regimens for the treatment of Helicobacter pylori in a population with a high metronidazole resistance rate. Aliment Pharmacol Ther 2001;15:411-6. (Pubitemid 32192865)
23. Megraud F. H. pylori antibiotic resistance: prevalence, importance, and advances in testing. Gut 2004;53:1374-84.
24. Rafeey M, Ghotaslou R, Nikvash S, Hafez AA. Primary resistance in Helicobacter pylori isolated in children from Iran. J Infect Chemother 2007;13:291-5. (Pubitemid 350059921)
25. Siavoshi F, Safari F, Doratotaj D, Khatami GR, Fallahi GH, Mirnaseri MM. Antimicrobial resistance of Helicobacter pylori isolates from Iranian adults and children. Arch Iran Med 2006;9:308-14. (Pubitemid 44803569)
26. Alarcon T, Domingo D, Lopez-Brea M. Antibiotic resistance problems with Helicobacter pylori. Int J Antimicrob Agents 1999;12:19-26. (Pubitemid 29241820)
27. Yilmaz O, Demiray E. Clinical role and importance of fluorescence in situ hybridization method in diagnosis of Helicobacter pylori infection and determination of clarithromycin resistance in H. pylori eradication therapy. World J Gastroenterol 2007;13:671-5.
28. Bindayna KM. Antibiotic susceptibilities of Helicobacter pylori. Saudi Med J 2001;22:53-7. (Pubitemid 32246278)
29. Megraud F. Epidemiology and mechanism of antibiotic resistance in Helicobacter pylori. Gastroenterology 1998;115:1278-82. (Pubitemid 28485621)
30. Kumala W, Rani A. Patterns of Helicobacter pylori isolate resistance to fluoroquinolones, amoxicillin, clarithromycin and metronidazole. Southeast Asian J Trop Med Public Health 2006;37:970-4. (Pubitemid 44844000)
31. Van Zwet A, Vandenbrouke-Grauls CM, Thijs JC, van der Wouden EJ, Gerrits MM, Kusters JG. Stable amoxicillin resistance in Helicobacter pylori. Lancet 1998;352:595.
32. Kuipers EJ, Israel DA, Kusters JG, Blaser MJ. Evidence for a conjugation-like mechanism of DNA transfer in Helicobacter pylori. J Bacteriol 1998;180:2901-5. (Pubitemid 29122117)
33. Han SR, Bhakdi S, Maeurer MJ, Schneider T, Gehring S. Stable and unstable amoxicillin resistance in Helicobacter pylori: should antibiotic resistance testing be performed prior to eradication therapy? J Clin Microbiol 1999;37:2740-1. (Pubitemid 29337314)
34. Thyagarajan SP, Ray P, Das BK, Ayyagari A, Khan AA, Dharmalingam S, et al. Geographical difference in antimicrobial resistance pattern of Helicobacter pylori clinical isolates from Indian patients: Multicentric study. J Gastroenterol Hepatol 2003;18:1373-8. (Pubitemid 38045850)
35. Sherif M, Mohran Z, Fathy H, Rockabrand DM, Rozmajzl PJ, Frenck RW. Universal high-level primary metronidazole resistance in Helicobacter pylori isolated from children in Egypt. J Clin Microbiol 2004;10:4832-4. (Pubitemid 39362416)